Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Infections 3Recurrence 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Torulopsis 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Stem Cell Transplant Complications 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Seminoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Mycoses 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukoplakia, Oral 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 31Busulfan 31Tacrolimus 24Antilymphocyte Serum 24Cyclosporine 22Mycophenolic Acid 20Filgrastim 20Radiotherapy 19Methotrexate 19Melphalan 17Whole-Body Irradiation 13Methylprednisolone 12Etoposide 12Cord Blood Stem Cell Transplantation 11Cytarabine 9Sirolimus 7Flow Cytometry 7Azacitidine 7Alemtuzumab 7Specimen Handling 6Psychiatric Rehabilitation 6Cyclosporins 6Biopsy 6sargramostim 5ruxolitinib 5Thiotepa 5fludarabine 4Rituximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myelodysplastic-Myeloproliferative Diseases × Fluconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡